Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:770-775
Published online before print February 6, 2003, doi: 10.1161/01.STR.0000057460.14810.3E
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/3/770    most recent
01.STR.0000057460.14810.3Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pei, Z.
Right arrow Articles by Cheung, R. T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pei, Z.
Right arrow Articles by Cheung, R. T. F.
Related Collections
Right arrow Animal models of human disease
Right arrow Neuroprotectors
Right arrow Other Research

(Stroke. 2003;34:770.)
© 2003 American Heart Association, Inc.


Original Contributions

Administration of Melatonin After Onset of Ischemia Reduces the Volume of Cerebral Infarction in a Rat Middle Cerebral Artery Occlusion Stroke Model

Zhong Pei, MBBS, MMed; Shiu Fun Pang, PhD Raymond Tak Fai Cheung, MBBS, PhD

From the Division of Neurology, Department of Medicine (Z.P., R.T.F.C.), and Department of Physiology (S.F.P.), Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong.

Reprint requests to Dr Raymond T.F. Cheung, Division of Neurology, University Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong. E-mail rtcheung{at}hkucc.hku.hk

Background and Purpose— In both permanent and transient 3-hour middle cerebral artery occlusion rat stroke models, a single intraperitoneal injection of melatonin at 5 or 15 mg/kg given before ischemia was shown to reduce infarct volume at 72 hours. The present study was conducted to examine the treatment time window when melatonin was commenced after onset of ischemia.

Methods— Adult male Sprague-Dawley rats were anesthetized to undergo right-sided middle cerebral artery occlusion for 3 hours. A single intraperitoneal injection of vehicle or melatonin at 5 mg/kg was given at 0, 1, or 3 hours after onset of ischemia. Other groups received multiple injections of vehicle or melatonin at 5 mg/kg with the first injection given at 1, 2, or 3 hours after onset of ischemia and the second and third injections at 24 and 48 hours, respectively. Multiple injections of melatonin at 15 mg/kg with the first injection given at 3 hours were also made. The infarct volume was determined at 72 hours.

Results— A single dose of melatonin at 5 mg/kg given at 0 or 1 but not 3 hours after onset of ischemia reduced the infarct volume. Multiple doses of melatonin at 5 mg/kg also reduced the infarct volume when the first dose was given at 1 or 2 but not 3 hours after onset. Significant hemodynamic effects were not observed.

Conclusions— Our results indicate that melatonin at 5 mg/kg given as a single injection or multiple injections protects against focal cerebral ischemia when commenced within 2 hours of onset.


Key Words: melatonin • middle cerebral artery occlusion • neuroprotection • stroke, experimental • rats




This article has been cited by other articles:


Home page
StrokeHome page
X. Wang, B. E. Figueroa, I. G. Stavrovskaya, Y. Zhang, A. C. Sirianni, S. Zhu, A. L. Day, B. S. Kristal, and R. M. Friedlander
Methazolamide and Melatonin Inhibit Mitochondrial Cytochrome C Release and Are Neuroprotective in Experimental Models of Ischemic Injury
Stroke, May 1, 2009; 40(5): 1877 - 1885.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. J. Reiter, D.-x. Tan, J. Leon, U. Kilic, and E. Kilic
When Melatonin Gets on Your Nerves: Its Beneficial Actions in Experimental Models of Stroke
Experimental Biology and Medicine, February 1, 2005; 230(2): 104 - 117.
[Abstract] [Full Text] [PDF]